In another study, DHA decreased NF-κB and p38 MAPK activation, which led to a reduction in vascular endothelial growth factor and biomarkers of PAH, MMP-2, MMP-9 [166]. The gene discussed is NFKB1; the disease is pulmonary arterial hypertension.